Position history for Quadrature Capital Ltd's holdings in ImmunityBio, Inc.
Quadrature Capital Ltd holds 436,869 shares of IBRX (ImmunityBio, Inc.), worth $865,001 as of 2025-Q4. The position was increased (++66.5% shares). IBRX represents 0.0% of Quadrature Capital Ltd's portfolio.
Current Value
$865,001
Current Shares
436,869
Total Value Change
+$222,143
Total Shares Change
+174,478
Other major holders of IBRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 436,869 |
+66.5% |
| $865,001 |
| 0.0% |
| $1.98 |
37 |
| 2025-Q3 | New | 262,391 | - | $642,858 | 0.0% | $2.57 | 34 |